

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 50mg | 180 pills | £1.61 | £322.31 £290.08 | |
| 50mg | 120 pills | £1.79 | £238.33 £214.50 | |
| 50mg | 90 pills | £1.89 | £188.94 £170.04 | |
| 50mg | 60 pills | £2.02 | £134.60 £121.14 | |
| 50mg | 30 pills | £2.22 | £74.09 £66.68 | |
| 50mg | 10 pills | £2.67 | £29.63 £26.66 | |
| 100mg | 180 pills | £2.37 | £472.98 £425.68 | |
| 100mg | 120 pills | £2.39 | £318.61 £286.75 | |
| 100mg | 90 pills | £2.51 | £250.68 £225.62 | |
| 100mg | 60 pills | £2.98 | £198.82 £178.93 | |
| 100mg | 30 pills | £3.11 | £103.72 £93.35 | |
| 100mg | 10 pills | £3.56 | £39.51 £35.56 | |
| 150mg | 180 pills | £1.52 | £305.02 £274.52 Best Price | |
| 150mg | 120 pills | £1.69 | £224.75 £202.28 | |
| 150mg | 90 pills | £1.88 | £187.70 £168.93 | |
| 150mg | 60 pills | £2.09 | £139.54 £125.58 | |
| 150mg | 30 pills | £2.33 | £77.79 £70.01 | |
| 150mg | 20 pills | £3.13 | £69.15 £62.23 | |
| 150mg | 10 pills | £3.35 | £37.04 £33.33 | |
| 200mg | 180 pills | £3.02 | £603.88 £543.49 Popular | |
| 200mg | 120 pills | £3.18 | £423.58 £381.22 | |
| 200mg | 90 pills | £3.53 | £353.19 £317.87 | |
| 200mg | 60 pills | £3.73 | £249.45 £224.50 | |
| 200mg | 30 pills | £4.61 | £154.36 £138.92 | |
| 200mg | 10 pills | £5.00 | £55.56 £50.00 |
Candida albicans is the most common fungal species responsible for mucosal infections in humans. Fluconazole, the active ingredient in Diflucan, is an azole antifungal used to treat a range of Candida infections by inhibiting fungal membrane synthesis. This action weakens the fungal cell membrane, leading to cell death or inhibited growth. In clinical practice, the medication is used for uncomplicated mucosal infections as well as selected systemic infections, under appropriate medical supervision.
Diflucan is taken by mouth as tablets or, in some formulations, as medicinal liquid. It is commonly prescribed when an infection is caused by susceptible Candida species, or when the clinical scenario suggests a high likelihood of such an infection. Absorption from the gut is generally efficient, and distribution occurs throughout the body, including some body fluids and tissues where fungal organisms may reside.
The use of fluconazole requires consideration of individual factors such as age, body weight, liver and kidney function, and potential drug interactions. Guidance on dosing, duration of therapy, and the choice of antifungal should be obtained from a clinician or pharmacist. If signs of a more serious or resistant infection appear, more intensive investigation and management may be required.
Diflucan is prescribed with attention to safety and monitoring requirements. Liver function tests and assessment of possible drug interactions are common components of therapy, particularly for longer courses or in individuals taking other medications. The information provided here is intended as an informative resource and should not replace professional medical advice.
In the United Kingdom, access to Diflucan may depend on local rules and clinical judgement. The official patient information leaflet that accompanies the product should be consulted for full dosing and safety details. If any instruction is unclear, contact a pharmacist or physician for clarification.
When used appropriately, Diflucan can be an effective option for managing Candida-related infections, with attention to contraindications and potential adverse effects. This section has described the role of fluconazole within the broader class of azole antifungals and its intended clinical applications.
Diflucan belongs to the azole class of antifungals. Its primary mechanism is to inhibit the enzyme lanosterol 14α-demethylase (a component of the fungal cytochrome P450 system), which is essential for converting lanosterol into ergosterol, a key component of the fungal cell membrane. Inhibition of this enzyme disrupts membrane synthesis and integrity, leading to increased membrane permeability and impaired fungal growth.
At a pharmacological level, fluconazole exhibits selective activity against fungal cytochrome P450 enzymes, with higher affinity for fungal enzymes than for most human enzymes. This selectivity reduces, but does not completely eliminate, the potential for human enzyme interactions. The result is a reduction in ergosterol content within the fungal cell membrane, which compromises membrane structure and function.
In simple terms, the drug weakens the fungal cell membrane, making it harder for the fungus to survive and reproduce. This action is most effective against Candida species that rely on ergosterol-containing membranes for viability. The effect is fungistatic in some contexts (inhibiting growth) and, under certain conditions or higher concentrations, may contribute to fungicidal activity (killing the organism).
Pharmacokinetically, fluconazole is rapidly absorbed after oral administration, with peak levels typically occurring within a few hours. It distributes widely in body tissues and fluids, including some areas where fungal infections may persist. It is primarily excreted unchanged by the kidneys, which has implications for individuals with reduced renal function. The pharmacokinetic profile supports its use in a range of mucosal and systemic candidiasis, subject to appropriate dosing and duration decisions.
Resistance can occur when Candida species alter the target enzyme or upregulate alternative pathways. In such cases, clinical efficacy may be reduced, and alternative antifungal agents or combination therapies might be considered. If an infection does not respond as expected, consultation with a clinician is advised, and referral for microbiological testing may be warranted.
Diflucan is approved for the treatment of fungal infections caused by susceptible Candida species. Typical indications include mucosal candidiasis, such as oral thrush and vulvovaginal candidiasis, as well as certain systemic infections in appropriate clinical contexts. The exact formulation, dose, and duration depend on the site and severity of infection, patient age, and comorbid conditions.
For uncomplicated mucosal candidiasis, Diflucan can provide a convenient oral therapy option. In more complex infections, extended courses or higher doses may be necessary, and therapy should be guided by a clinician based on the organism involved and patient-specific factors. In all cases, treatment should be completed as directed, even if symptoms improve earlier than expected.
Diflucan may also be used in the management of certain cryptococcal infections in conjunction with other antifungal therapy and under specialist supervision. In all such scenarios, therapy is tailored to the individual patient and local guidelines. If a clinician suspects a concurrent bacterial infection or another fungal organism, additional or alternative therapies may be considered.
Pregnancy status, lactation, age, and kidney or liver function influence the choice of antifungal therapy and duration. The official patient information leaflet provides complete details on approved indications, dosing ranges, and safety context. When in doubt, a healthcare professional should be consulted to determine suitability for a given infection.
In the context of a suspected fungal infection that is not clearly mucosal, or when resistance is suspected, culture and sensitivity testing may be advised to guide therapy. The information presented here is intended to reflect common clinical practice and is not a substitute for professional recommendations based on individual clinical assessment.
Off-label use refers to prescribing fluconazole for indications not formally approved in official guidelines. Such uses are considered by clinicians based on available evidence, local resistance patterns, and patient-specific factors. When off-label use is contemplated, informed discussion and careful monitoring are essential.
Common off-label areas include certain dermatologic and nail infections, complex fungal infections in immunocompromised patients, and some pediatric or neonatal infections where evidence supports benefit. In each case, the decision to treat off-label should rely on clinical judgment, pathogen susceptibility, and risk–benefit assessment.
Fluconazole’s activity against a range of Candida species makes it usable in some mixed infection scenarios, but resistance among non-albicans species can limit effectiveness. When resistance is possible, alternative antifungal strategies or combination therapy may be considered under specialist guidance. If uncertainty exists about an indication, check the official leaflet or consult a pharmacist or clinician for guidance.
In settings such as hospital admission or specialized clinics, fluconazole may be used as part of a broader antifungal regimen for selected systemic infections. The choice of fluconazole versus other azoles or polyenes will depend on patient factors, drug interactions, and infection location. For patients outside standard indications, clearance with a clinician is advised prior to initiating therapy.
Off-label use should be documented in the patient’s medical record, with clear reasoning and monitoring plans. If any unexpected adverse effects or lack of response occurs, prompt medical review is recommended. The information provided here is for informational purposes only and does not replace clinical judgement.
Oral administration is the common route for Diflucan. The tablets are intended to be swallowed with a cup of water, with or without food depending on tolerance and the prescriber’s instruction. Absorption is generally unaffected by meals, though food tolerance may vary between individuals.
Duration of therapy depends on the infection type and severity. For uncomplicated mucosal candidiasis, a single dose or a short course may be adequate, while more extensive infections typically require a longer course. The exact dose and course length should be determined by a clinician, and the official patient information leaflet should be consulted for specifics. If uncertainties remain, a pharmacist may assist with interpretation of the guidance.
In some instances, suspension formulations are available for patients who cannot swallow tablets. The suspension may have different dosing considerations, and accurate measurement using an appropriate dosing device is essential. Do not alter the prescribed course or discontinue therapy without medical guidance.
When a dose is missed, instructions from the clinician or leaflet should be followed. In general, if a dose is skipped, it should be taken as soon as remembered unless it is near the time of the next dose. Do not double the next dose to compensate for a missed one; instead, resume the regular dosing schedule and consult a clinician if there is concern about treatment adequacy.
Long-term or repeated courses of fluconazole require careful monitoring for liver function and potential drug interactions. The need for ongoing therapy should be regularly reassessed by a clinician. If symptoms persist beyond the expected course, or new symptoms develop, seek medical advice promptly.
Diflucan is generally well tolerated, but potential adverse effects exist. Common reactions include gastrointestinal discomfort, headaches, and skin rashes. Most side effects are mild and resolve with continued therapy or after completion of treatment. Seek medical advice if side effects are persistent, worsening, or cause concern.
Contraindications include known hypersensitivity to fluconazole or to other azole antifungals. Severe liver disease or active hepatic impairment may necessitate avoidance or careful monitoring. In such cases, alternative antifungal therapy may be more appropriate. The risk–benefit balance should be assessed by a clinician before initiating therapy.
Hepatic monitoring may be indicated, particularly in patients receiving longer courses, those with pre-existing liver disease, or individuals taking multiple medications that can affect liver function. Report any signs of liver injury, such as jaundice, dark urine, pale stools, or right upper abdominal pain, promptly to a healthcare professional.
Fluconazole can interact with several other medicines. Potential interactions include those that prolong the QT interval, anticoagulants, certain antidiabetic agents, and other systemic antifungals. A comprehensive medication history should be reviewed prior to starting therapy to identify potential interactions and necessary dose adjustments or monitoring. If uncertain, a pharmacist should be consulted before initiating treatment.
Pregnancy and breastfeeding status influence treatment decisions. Fluconazole may be used during pregnancy only when advised by a clinician after weighing benefits against potential risks. If pregnancy occurs during treatment, seek professional guidance promptly. If breastfeeding is planned or ongoing, discuss with a clinician whether continued therapy is appropriate.
Pregnancy: In pregnancy, the use of fluconazole should be carefully considered. Some guidelines advise restraint unless benefits clearly outweigh potential risks. A clinician will evaluate the infection, the pregnancy stage, and alternative options before recommending therapy. If used during pregnancy, careful monitoring is important.
Lactation: Fluconazole passes into breast milk in small amounts. Decisions regarding continuation of breastfeeding while on therapy should be made by a clinician, considering the infection being treated and the potential benefit to the mother. Alternative treatment options may be discussed if consensus suggests a higher risk to the infant.
Pediatrics: Fluconazole has pediatric indications, with dosing adjusted for age and weight. Pediatric use should be managed by a clinician who can assess growth, development, and infection severity. In certain neonatal or premature populations, careful monitoring and specialist input may be required.
Renal impairment: The drug is primarily excreted by the kidneys. In individuals with reduced kidney function, dose adjustments and careful monitoring may be necessary to avoid accumulation and potential toxicity. A clinician should determine whether therapy is appropriate and how to adjust the dose, if needed.
Hepatic impairment: In patients with liver disease, liver function and drug exposure should be considered. Fluconazole can affect liver enzymes, and dose adjustments or alternative therapy may be warranted in moderate to severe hepatic impairment. Close monitoring is recommended in such scenarios.
Fluconazole can interact with a number of medicines. Important interactions may alter the effectiveness of therapy or increase the risk of adverse effects. A comprehensive review of all medications, supplements, and herbal products should be performed before starting treatment. If any potential interaction is identified, a clinician or pharmacist should be consulted to determine the safest course of action.
Some interactions are more prominent with longer courses or higher doses. In certain cases, additional monitoring or dose adjustment may be necessary. Patients should be aware of potential interactions with anticoagulants, antidiabetic medications, immunosuppressants, and other antifungal agents. If uncertain, seek professional advice prior to commencing therapy.
If any new medication is started during Diflucan therapy, inform the prescribing clinician. A healthcare professional may need to reassess the antifungal treatment plan and adjust therapy accordingly. This approach helps to maintain efficacy while minimizing safety concerns.
General guidance on concomitant use with alcohol is not to rely on complete avoidance unless advised by a clinician. Excessive alcohol consumption can increase the risk of liver injury, particularly when combined with medications that stress hepatic function. If liver-related symptoms occur, seek urgent medical assessment.
| Indication | Diflucan (fluconazole) | Related azoles (example: itraconazole) |
|---|---|---|
| Uncomplicated vaginal candidiasis | Commonly used; convenient oral dosing | Alternative option; dosing often differs; absorption may be variable |
| Oral candidiasis (thrush) | Effective for mucosal infection | May require different dosing strategy; local treatments also available |
| Systemic Candida infections | Used in selected cases; dependence on organism susceptibility | Sometimes preferred for broader spectrum or specific species; consult specialist guidance |
| Cryptococcal infections (in certain contexts) | Used as part of combination therapy under specialist supervision | Other azoles or amphotericin B may be preferred depending on stage and patient factors |
Store Diflucan tablets in a cool, dry place away from direct heat and moisture. Keep the container tightly closed and out of reach of children. Do not use after the expiry date printed on the packaging. If a suspension is used, shake well before measuring the dose and use a suitable dosing device to ensure accuracy.
Adherence to the prescribed course is important to maximise effectiveness and reduce the risk of recurrence or resistance. If symptoms persist or worsen after completing treatment, or if new symptoms develop, seek medical advice promptly. Do not take additional courses without consulting a clinician.
Diflucan should only be used under medical supervision in individuals with known fungal infections or when a clinician has judged it appropriate. If an individual has previously experienced an allergic reaction to fluconazole or other azole antifungals, inform the clinician before starting therapy. The information herein is intended to support, not replace, professional medical assessment.
When obtaining Diflucan from an online pharmacy, ensure the prescription requirements and verification processes comply with local regulations. Do not use medications that are past their expiry date or that appear compromised. If there is any uncertainty regarding authenticity or safety, contact a pharmacist for verification before use.
Diflucan can be taken with or without food, depending on tolerance. Absorption is generally not significantly affected by food, but some individuals may experience fewer stomach upset symptoms when taken with food. If there is any uncertainty, consult the official leaflet or a pharmacist for guidance.
Moderate alcohol consumption is not universally contraindicated, but both alcohol and fluconazole may stress the liver in some individuals. If liver disease is present or if there is concern about liver health, avoid heavy drinking and seek guidance from a clinician. Monitor for signs of liver trouble such as jaundice, unusual fatigue, or dark urine and report these promptly.
If a dose is missed, take it as soon as remembered unless it is near the time for the next scheduled dose. Do not double the next dose to make up for the missed one. If there is any doubt about how to proceed, contact a pharmacist or clinician for advice.
Response times vary with the type and severity of infection. Some symptoms may improve within a few days, while others may require a full course of therapy. If there is no improvement after completing the course or if symptoms worsen, seek medical review.
Fluconazole has pediatric indications in appropriate cases. Dosing is adjusted for weight and age, and treatment should be supervised by a clinician. If there is uncertainty about suitability for a child, a pharmacist or clinician should be consulted before use.
Pregnancy requires careful risk assessment. Fluconazole may be considered when benefits outweigh potential risks and a clinician provides specific guidance. If pregnancy occurs during treatment, seek medical advice promptly to determine the best course of action.
Liver-related symptoms warrant prompt medical evaluation. Signs may include yellowing of the skin or eyes, dark urine, pale stools, persistent nausea, or severe fatigue. A clinician may adjust the treatment plan or discontinue therapy if liver injury is suspected.
Interactions with other medicines can occur. A comprehensive medication review is essential before starting therapy. If any potential interactions are identified, a clinician may adjust dosing or monitor more closely. Do not start or stop medicines without professional advice.
Complete the full prescribed course unless advised otherwise by a clinician. Stopping early may increase the risk of relapse or resistance and reduce the likelihood of a successful outcome.
Chronic or recurrent infections require careful evaluation to identify underlying factors such as immune status or persistent colonisation. A clinician may propose a maintenance strategy, longer treatment, or alternative therapies based on individual circumstances. Regular consultation is advised for recurrent episodes.
Renal or hepatic impairment can affect fluconazole therapy. Dose adjustments or alternative treatments may be necessary, and close monitoring is advised. A clinician will determine the safest and most effective approach based on the degree of impairment and overall health status.
Discontinuation should follow clinical guidance. Stopping early without a clinician’s instruction may lead to incomplete eradication of the infection and possible recurrence. If symptoms recur after stopping, contact a clinician for a reassessment.
The requirement for a prescription may vary by local rules and the specific product formulation. If a prescription is required, it should be obtained before dispensing. If there is any doubt, the online pharmacy platform or a local pharmacist can confirm current regulations. Always use Diflucan under professional supervision when indicated.
Recurrence after treatment warrants clinical review to determine whether reinfection, resistance, or another health issue is present. Additional diagnostic testing and a revised treatment plan may be recommended by a clinician. Do not assume the same approach will be effective without guidance.
14–21 days. Free from £148.20 .
5–9 days. £22.23
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
